This inventor holds 7 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Université Paul Sabatier (Toulouse III), National Institute of Health and Medical Research, Institut Claudius Regaud. Active years: 1994-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 162 
5 out of 1,853 
3 out of 6 Years Active: 1994-2026
Title: **Gilles Favre: A Pioneering Inventor in Cancer Research**
Introduction
Gilles Favre, based in Toulouse, France, is an accomplished inventor known for his significant contributions to the field of cancer research. With six patents to his name, Gilles has made a substantial impact through innovative methods aimed at understanding and treating various forms of cancer.
Latest Patents
Among his most recent patents, Favre has developed methods for screening modulators of binding between GTPase and GTPase binding domains. This invention encompasses methods and kits designed for the detection of protein-protein interactions, particularly focusing on the binding dynamics between two polypeptides within cells. His innovative approach involves providing cells that express specific polypeptides and utilizing fluorescence detection to determine binding events. Moreover, he has also patented methods and pharmaceutical compositions for treating cancers related to the activation of the MAPK pathway. This research highlights the role of SLITRK6 in mediating resistance to MAPK inhibitors, offering new strategies to enhance antitumor effects and minimize relapse.
Career Highlights
Gilles has had a distinguished career within reputable institutions such as the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Université Paul Sabatier Toulouse III. His work is characterized by a deep commitment to advancing research methodologies and developing novel therapeutic approaches for cancer treatment.
Collaborations
Throughout his career, Gilles has collaborated with notable coworkers including Aurelien Olichon and Laura Keller. These partnerships have fostered an environment of innovation and knowledge exchange, further propelling Gilles’ contributions to the field.
Conclusion
In summary, Gilles Favre stands out as an influential inventor whose patents reflect his dedication to enhancing the understanding and treatment of cancer. His innovative methods pave the way for future advancements in the field, showcasing the vital role of inventors in shaping medical research and therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile